Some research suggests that individuals who have lost significant weight may experience lower metabolic rates than predicted for their new body size, though this varies considerably between individuals
Retatrutide (also known as LY-3437943) is an experimental medication developed by Eli Lilly that is being studied as a next-generation treatment for obesity, overweight, and related metabolic conditions such as type 2 diabetes
Local communication on and within bone controls bone remodelling
Myth GLP-1 medications are a quick fix Myth Everyone loses weight in the same way Myth GLP-1 medications simply "turn off hunger" Myth Online programs offer the same care as medical clinics
Increasingly, as people strive to achieve their wellness goals, modern weight loss medications, such as Ozempic, Mounjaro, and Wegovy, are being used to jump-start or maintain that path to health
Ozempic has a black box warning from the FDA for the risk of thyroid tumors or thyroid cancer